Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells

Closed Pre-Solicitation Posted

Not the latest version. See the latest pre-solicitation from .

Solicitation number
75N92019R0052
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

PSC
Not on record
More information

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health National Heart Lung and Blood Institute seeks to establish a Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells. Interested parties must have the capability to collect, process, cryopreserve, store, and distribute human induced pluripotent stem cell lines derived from patients with lung diseases. Evaluation will consider the offeror's technical approach, facilities, staff expertise, standard operating procedures, and track record of managing similar biorepositories. The deadline for questions is July 26, 2019.

There is no set-aside designated for this requirement. The projected NAICS code is 541711 and PSC code is R425. As the incumbent for this work, the National Disease Research Interchange would likely continue in this role. The agency estimates establishing a biorepository with a minimum of 50 cell lines derived from various lung diseases, with storage and distribution services continuing for at least 10 years.

Notice text

Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells.

Notice history

Notice Type Posted
Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells Latest pre-solicitation Pre-Solicitation
This notice Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors